CCR7 and neoplasm: Similar findings have been reported with dual armoring with IL-7 and CCL21, another CCR7 ligand, which also promoted T-cell and DC recruitment, increased central memory phenotype T-cells, and improved tumor control in an antigen-heterogeneous tumor model (197).